Clinical significance of a new oncogenic factor P5CR1 in gastric cancer
C.-X. Zhang, Y. Li, W.-H. Gong, J. Zhang Department of Oncology, The First Affiliated Hospital of Dalian Medical University, Dalian, China.
The article “Clinical significance of a new oncogenic factor P5CR1 in gastric cancer, by C.-X. Zhang, Y. Li, W.-H. Gong, J. Zhang, published in Eur Rev Med Pharmacol Sci 2020; 24(5): 2421-2427–DOI: 10.26355/eurrev_202003_20509–PMID: 32196593” has been withdrawn from the authors.
The Publisher apologizes for any inconvenience this may cause.
https://www.staging.europeanreview.org/article/20509
Free PDF Download
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License
To cite this article
C.-X. Zhang, Y. Li, W.-H. Gong, J. Zhang
Clinical significance of a new oncogenic factor P5CR1 in gastric cancer
Eur Rev Med Pharmacol Sci
Year: 2020
Vol. 24 - N. 16
Pages: 8248-8248
DOI: 10.26355/eurrev_202008_22589